Market Cap (In TWD)
1.06 Billion
Revenue (In TWD)
-
Net Income (In TWD)
-51.61 Million
Avg. Volume
49.83 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7.31-11.2
- PE
- -
- EPS
- -
- Beta Value
- -0.254
- ISIN
- TW0006652001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Hong-Jen Chang M.D., M.P.H., M.S.
- Employee Count
- -
- Website
- https://www.eusol-biotech.com
- Ipo Date
- 2018-08-29
- Details
- Eusol Biotech Co.,Ltd. focuses on research and development of new biotech drugs for sleep disorders. Its pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for repairing neuron function; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with sedative effect. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
More Stocks
-
1966Takada Corporation
1966
-
VESTVestiage, Inc.
VEST
-
2439
-
PKLBFPerk Labs Inc.
PKLBF
-
EFSCP
-
MOL
-
0020SenseTime Group Inc.
0020
-
UOG